A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 567.77
GOOG 525.16
MSFT 39.86
BAC 16.34
FB 60.87

Recently Added

HORI 0.25
NDLS 36.98
VJET 17.14
STLY 2.96
GUID 9.18

Gaining Speed

NDLS 36.98
VJET 17.14
HORI 0.25
HPJ 5.09
GILD 74.08

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!